Exim Bank study highlights priority focus areas, policy initiatives for sectors including pharma Read more
Kyowa Kirin gets EC approval for CRYSVITA (burosumab) to treat X-Linked hypophosphataemia in older adolescents and adults Read more
Oral GnRH antagonists have potential in female health beyond endometriosis pain and uterine fibroids Read more
EMA to review MAA for avalglucosidase alfa, enzyme replacement therapy to treat Pompe disease Read more